Immune checkpoint inhibitor-induced myocarditis in cancer patients: a case report and review of reported cases

BACKGROUND: Immune checkpoint inhibitor (ICI) induced myocarditis is a rare, severe, and often fatal adverse event. Evidence to guide appropriate immunosuppressive therapy is scarce. We present a case of ICI-induced myocarditis and a review of ICI-induced myocarditis cases to determine the most effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Matzen, Emma, Bartels, Lars Erik, Løgstrup, Brian, Horskær, Stine, Stilling, Christina, Donskov, Frede
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351114/
https://www.ncbi.nlm.nih.gov/pubmed/34365980
http://dx.doi.org/10.1186/s40959-021-00114-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351114/
https://www.ncbi.nlm.nih.gov/pubmed/34365980
http://dx.doi.org/10.1186/s40959-021-00114-x

Ejemplares similares